Interestingly, β-blockers, commonly used as antihypertension drugs, have also been identified as decreasing cell proliferation and cell migration in estrogen receptor positive and negative breast cancer cells [14, 15], but also in other tumor types, including lung, pancreas, prostate, colon, stomach and ovarian cancer [30]. This evidence concerns the gene ESR1 and ovarian carcinoma.